Basic Study
Copyright ©The Author(s) 2023.
World J Psychiatry. Sep 19, 2023; 13(9): 630-644
Published online Sep 19, 2023. doi: 10.5498/wjp.v13.i9.630
Table 2 miRNA levels by groups of more and less severe symptoms of cognitive impairment or depress in cerebral small vessel disease patients, n (%)
Assessment Scale
More severe disease (below the average score)
Less severe disease (beyond the average score)
P value of miRNA-levels
Patients
miRNA level
Patients
miRNA level
MoCA45 (56.25)1.18 ± 0.3235 (43.75)2.15 ± 0.450.010
EFA40 (50)1.25 ± 0.4040 (50)2.30 ± 0.500.0092
HAMD50 (62.5)1.10 ± 0.3530 (37.5)2.20 ± 0.550.030
BDI38 (47.5)1.15 ± 0.3842 (52.5)2.25 ± 0.480.0012